Paclitaxel is a broad‐spectrum anticancer compound, which was derived mainly from a
medicinal plant, in particular, from the bark of the yew tree Taxus brevifolia Nutt. It is a …

Colloidal drug delivery systems have been extensively investigated as drug carriers for the
application of different drugs via different routes of administration. Systems, such as solid …

The rapid development of nanotechnology provides alternative approaches to overcome
several limitations of conventional anti-cancer therapy. Drug targeting using functionalized …

The lung is an attractive target for drug delivery because of the ease of non-invasive
administration via inhalation, bypassing metabolism in the liver, direct delivery to the …

Localised and targeted potential of nanocarrier for the eminent anticancer agent paclitaxel
(PTX) could provide a great platform towards improvement of efficacy with reduction in …

The purpose of this study was to develop a novel lipid–polymer hybrid drug carrier
comprised of folate (FA) modified lipid-shell and polymer-core nanoparticles (FLPNPs) for …

Late-stage diagnosis of lung cancer occurs~ 95% of the time due to late manifestation of its
symptoms, necessitating rigorous treatment following diagnosis. Existing treatment methods …

Nanoparticles are particles having a size range of 1 and 100 nanometers, defined as a small
object behaving as a complete unit with respect to the drug transport and therapeutic …

Bacterial infections of the pulmonary system are increasing. With almost half of today's
infections being caused by strains of bacteria that are resistant to existing conventional …

Magnetic nanoparticles are regarded as a promising drug delivery vehicle with the improved
efficacy and lowered side effects for antitumor therapy. Herein, the poly lactic-co-glycolic …